Form 4: Home BancShares CEO John Allison to Acquire Shares Under Pre-Planned Grant

Sentiment:

Insider Ownership Change


Home BancShares Inc. Chairman and CEO John W. Allison is set to acquire 3,508 shares of common stock on July 28, 2025, as part of a pre-scheduled transaction under a Rule 10b5-1 plan.

Summary

  • John W. Allison, Chairman & CEO and Director of Home BancShares Inc. (HOMB), will acquire 3,508 shares of common stock on July 28, 2025, at a price of $0 per share.
  • This transaction is a pre-scheduled acquisition under a Rule 10b5-1 plan, as indicated by the check box for Rule 10b5-1(c).
  • Following this transaction, Mr. Allison's direct beneficial ownership of common stock will be 5,689,424 shares.
  • His total beneficial ownership also includes 156,000 shares of restricted stock and 300,000 shares of performance-based common stock held directly.
  • Indirect holdings include 1,605 shares via IRA, 67,328 shares via Capital Buyers, 865,360 shares via his wife, and 27,323.742 shares via a 401(k) plan, which includes 373.5154 shares acquired since the last filing.
  • Restricted stock granted on January 20, 2023, and January 19, 2024, will cliff vest on their third anniversaries, while other restricted stock grants from these dates and January 17, 2025, will vest in 33 1/3% installments over three years beginning on their first anniversaries.
  • Performance stock awarded on January 20, 2023, will vest after December 31, 2025, and performance stock awarded on January 19, 2024, will vest after December 31, 2026, both contingent on Compensation Committee certification of performance measures.
  • Performance stock awarded on January 17, 2025, will vest in three equal annual installments upon certification of annual performance measures by the Compensation Committee.

Sentiment

Score: 6

Explanation: Slightly positive. The acquisition of shares by the CEO, even if a grant, indicates continued alignment of interests. The transaction is pre-planned, reducing speculative impact.

Positives

  • The acquisition of 3,508 shares by the Chairman and CEO, even if a grant, indicates continued alignment of management interests with shareholders.
  • The transaction being executed under a Rule 10b5-1 plan demonstrates a structured and pre-planned approach to insider transactions, promoting transparency and compliance.

Risks

  • Vesting of 300,000 performance-based common stock is contingent on the Compensation Committee certifying certain performance measures, introducing uncertainty regarding the final number of shares that will vest.
  • Restricted stock grants have cliff vesting or installment vesting schedules over multiple years, meaning the full benefit is not immediately realized and is subject to continued employment and company performance.

Future Outlook

The vesting of a significant portion of executive compensation, particularly performance-based stock, is tied to future company performance and certification by the Compensation Committee, aligning executive incentives with long-term shareholder value creation.

Industry Context

This filing reflects a standard practice in executive compensation within the financial services industry, where stock grants and performance-based awards are used to incentivize long-term performance and align management interests with shareholders. The use of a Rule 10b5-1 plan is common for insiders to manage their stock transactions in compliance with insider trading regulations.

Stakeholder Impact

  • Shareholders: The transaction increases the CEO's direct ownership, potentially signaling confidence and aligning executive incentives with shareholder returns. The vesting schedules tie a significant portion of executive compensation to long-term company performance.
  • Employees: The structure of executive compensation, including restricted and performance-based stock, sets a precedent for incentive structures within the company.

Next Steps

  • Continued vesting of restricted stock awards on their respective anniversary dates.
  • Certification by the Compensation Committee regarding performance measures for performance-based stock awards after December 31, 2025, and December 31, 2026, and annually thereafter for the January 17, 2025 award.

Key Dates

DateDescription
2023-01-20Grant date for certain restricted stock and performance stock awards.
2024-01-19Grant date for certain restricted stock and performance stock awards.
2024-01-20First anniversary of January 20, 2023 restricted stock grant, beginning of 33 1/3% installment vesting.
2025-01-17Grant date for certain restricted stock and performance stock awards.
2025-01-19First anniversary of January 19, 2024 restricted stock grant, beginning of 33 1/3% installment vesting.
2025-07-28Scheduled transaction date for the acquisition of 3,508 shares of common stock.
2025-07-29Filing date of the Form 4.
2025-12-31Earliest date for vesting of performance stock awarded on January 20, 2023, subject to Compensation Committee certification of performance measures.
2026-01-17First anniversary of January 17, 2025 restricted stock grant, beginning of 33 1/3% installment vesting for restricted stock and first annual installment for performance stock.
2026-01-20Third anniversary of January 20, 2023 restricted stock grant, cliff vesting date for certain awards.
2026-12-31Earliest date for vesting of performance stock awarded on January 19, 2024, subject to Compensation Committee certification of performance measures.
2027-01-19Third anniversary of January 19, 2024 restricted stock grant, cliff vesting date for certain awards.

Keywords

Home BancShares, HOMB, John W. Allison, Insider Trading, Form 4, Beneficial Ownership, Stock Grant, Executive Compensation, Rule 10b5-1, Restricted Stock, Performance Stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.